U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07353450) titled 'A Study of Cizutamig for Patients With Ulcerative Colitis' on Dec. 26, 2025.
Brief Summary: A Study of Cizutamig for Patients with Ulcerative Colitis
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis (UC)
Intervention:
BIOLOGICAL: cizutamig
Cizutamig will be dosed according to the protocol
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ruijin Hospital
Disclaimer: Curated by HT Syndication....